Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 20, 2026 09:00 ET | Source: Orion Oyj

Orion Pharman ODM-212-molekyyli on saanut FDA:n harvinaislääkestatuksen (Orphan Drug Designation) mesoteliooman hoidossa

ORION OYJ LEHDISTÖTIEDOTE 20.4.2026 KLO 16.00 Orion Pharman ODM-212-molekyyli on saanut FDA:n harvinaislääkestatuksen (Orphan Drug Designation) mesoteliooman hoidossa Orion...
April 20, 2026 09:00 ET | Source: Orion Oyj

Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA

ORION CORPORATION PRESS RELEASE 20 APRIL 2026 at 16.00 EEST Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA Orion Corporation (Orion Pharma) today...